Endocrinology 149 , 49124920 (2008)
Trulicity is the brand name for dulaglutide, a once-weekly injectable GLP-1 receptor agonist used to treat type 2 diabetes
Therefore, GLP-1RA is a promising group of medications to treat obesity, improve glycemic control, and decrease the risk of complications in these patients
At Real Peptides, we provide all the information and resources our customers need to perform this step correctly
Hypoglycemia Despite having a pronounced anti-hyperglycemic effect, GLP-1 RAs are not typically associated with hypoglycemia when used as monotherapy
The goal is to give you clear, science-based information so you can decide if this peptide treatment is right for you